Image: Stratos Brilakis, via Shutterstock
Chemical and drug companies say US regulations are stifling materials and pharmaceuticals research
Industry groups have criticised policies being enacted by the administration of US president Joe Biden, pushing back against his characterisation of elements of his presidency in his annual State of the Union address.
In his speech on 7 March, Biden said that the US was “investing more in R&D than ever before” thanks to the Chips and Science Act, which authorised spending on semiconductors as well as other research and innovation.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.